Inhibitory activities of indolizine derivatives: a patent review

References

• Katritzky A, Ramsden C, Taylor R. Comprehensive heterocyclic chemistry III. 1st ed. A Review of the Literature 1995–2007. Amsterdam: Elsevier Science; 2008.
   Google Scholar
• Lee Y. Systematic exploration of indolizine-based small fluorescent molecules. 1st ed. Singapore: Springer; 2018.
   Google Scholar
• Sandeep C, Venugopala KN, Khedr MA. Review on chemistry of natural and synthetic indolizines with their chemical and pharmacological properties. J Basic Clinic Pharm. 2017;8:49–60.
   Google Scholar
• Sharma V, Kumar V. Indolizine: A biologically active moiety. Med Chem Res. 2014;23:3593–3606.
   Web of Science ®Google Scholar
• Ratmanova NK, Andreev IA, Leontiev AV, et al. Strategic approaches to the synthesis of pyrrolizidine and indolizidine Alkaloids. Tetrahedron. 2020;76:131031.
   Web of Science ®Google Scholar
• Michael JP. Indolizidine and quinolizidine alkaloids. Nat Prod Rep. 2008;25:139–165.
   PubMed Web of Science ®Google Scholar
• Tan X-M, Chen AJ, Wu B, et al. Advance of swainsonine biosynthesis. Chin Chem Lett. 2018;29:417–422.
   Web of Science ®Google Scholar
• Bunsupa S, Yamazaki M, Saito K. Lysine-derived alkaloids: overview and update on biosynthesis and medicinal applications with emphasis on quinolizidine alkaloids. Mini-Rev Med Chem. 2017;17:1002–1012.
   PubMed Web of Science ®Google Scholar
• Ren Z, Song R, Wang S, et al. The biosynthesis pathway of swainsonine, a new anticancer drug from three endophytic fungi. J Microbiol Biotechnol. 2017;27:1897–1906.
   PubMed Web of Science ®Google Scholar
• Cook D, Gardner DR, Pfister JA, et al. Biosynthesis of natural products in plants by fungal endophytes with an emphasis on swainsonine. Recent Adv Phytochem. 2014;44:23–41.
   Google Scholar
• Martinez A, Robles CA, Roper JM, et al. Detection of swainsonine-producing endophytes in patagonian astragalus species. Toxicon. 2019;171:1–6.
   PubMed Web of Science ®Google Scholar
• Wu C, Han T, Lu H, et al. The toxicology mechanism of endophytic fungus and swainsonine in locoweed. Environ Toxicol Pharmacol. 2016;47:38–46.
   PubMed Web of Science ®Google Scholar
• Kristanc L, Kreft S. European medicinal and edible plants associated with subacute and chronic toxicity part II: plants with hepato-, neuro-, nephro- and immunotoxic effects. Food Chem Toxicol. 2016;92:38–49.
   PubMed Web of Science ®Google Scholar
• Diaz GJ. Toxicosis by plant alkaloids in humans and animals in Colombia. Toxins (Basel). 2015;7:5408–5416.
   PubMed Web of Science ®Google Scholar
• Wu C, Wang W, Liu X, et al. Pathogenesis and preventive treatment for animal disease due to locoweed poisoning. Environ Toxicol Pharmacol. 2014;37:336–347.
   PubMed Web of Science ®Google Scholar
• Cook D, Gardner DR, Pfister JA. Swainsonine-containing plants and their relationship to endophytic fungi. J Agric Food Chem. 2014;62:7326–7334.
   PubMed Web of Science ®Google Scholar
• Henciya S, Seturaman P, James AR, et al. Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa). J Food Drug Anal. 2017;25:187–196.
   PubMed Web of Science ®Google Scholar
• Saxena PK, Nanda D, Gupta R, et al. A review on Ipomoea carnea: an exploration. Internat Res J Pharm. 2017;8:1–8.
   Google Scholar
• Hao B-C, Liang J-P, Yang X-P, et al. Research advances in the detoxificating preparation of swainsonine in “Locoweed” and its application to anti-tumor. Med Plant. 2012;3:78–80.
   Google Scholar
• Vemula VR, Vurukonda S, Bairi CK. Indolizine derivatives: recent advances and potential pharmacological activities. Internat J Pharm Sci Rev Res. 2011;11:159–163.
   Google Scholar
• Gerber-Lemaire S, Juillerat-Jeanneret L. Studies toward new anti-cancer strategies based on α-mannosidase inhibition. Chimia (Aarau). 2010;64:634–639.
   PubMed Web of Science ®Google Scholar
• Asai M, Takemoto Y, Deguchi A, et al. An asymmetric synthesis of (+)-monomorine I. Tetrahedron: Asymmetry. 2017;28:1582–1586.
   Google Scholar
• Kennedy S, Kethe A, Qarah A, et al. Superacid-promoted synthesis of indolizidine derivatives. Tetrahedron Lett. 2018;59:1932–1935.
   Web of Science ®Google Scholar
• Chakraborty I, Jana S. Synthetic developments on the indolizidine alkaloid, harmicine. Synthesis. 2013;45:3325–3331.
   Web of Science ®Google Scholar
• Sun LR, Li X, Wang SX. Two new alkaloids from the rhizome of Polygonatum sibiricum. J Asian Nat Prod Res. 2005;7:127–130.
   PubMed Web of Science ®Google Scholar
• Dinsmore A, Mandy K, Michael JP. Total synthesis of two novel 5,6,7,8-tetrahydroindolizine alkaloids polygonatines A and B. Org Biomol Chem. 2006;4:1032–1037.
   PubMed Web of Science ®Google Scholar
• Choudhary MI, Nawaz SA, Zaheer-ul-Haq. Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer’s disease therapy. Biochem Biophys Res Commun. 2005;332:1171–1177.
   PubMed Web of Science ®Google Scholar
• Gundersen LL, Charnock C, Negussiea AH. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. Eur J Pharm Sci. 2007;30:26–35.
   PubMed Web of Science ®Google Scholar
• Alcouffe C, Herbert C, Lassalle G. Preparation of indolizine derivatives for treating cancers and cardiovascular disorders. PCT Int. Appl WO 2012004731 A1 20120112. 2012.
   Google Scholar
• Huang W, Zuo T, Jin HW, et al. Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF–Elongin C interaction inhibitors. Mol Diversity. 2013;17:221–243.
   PubMed Web of Science ®Google Scholar
• Dawood KM, Abdel-Gawad H, Ellithey M. Synthesis, anticonvulsant and anti-inflammatory activities of some new benzofuran-based heterocycles. Arch Pharm Chem Life Sci. 2006;339:133–140.
   PubMed Web of Science ®Google Scholar
• Chandrashekharappa S, Venugopala KN, Venugopala R, et al. Qualitative anti-tubercular activity of synthetic ethyl 7-acetyl- 2-substituted-3-(4-substituted benzoyl) indolizine-1-carboxylate analogues. J Appl Pharm Sci. 2019;9:124–128.
   Google Scholar
• Harit VK, Ramesh NG. Amino-functionalized iminocyclitols: synthetic glycomimetics of medicinal interest. RSC Adv. 2016;111:109528–109607.
   Google Scholar
• Massicot F, Messire G, Vallee A, et al. Regiospecific formation of sugar-derived ketonitrone towards unconventional C-branched pyrrolizidines and indolizidines. Org Biomol Chem. 2019;17:7066–7077.
   PubMed Web of Science ®Google Scholar
• Chen J, Lv H, Hu J, et al. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway. Canc Lett. 2016;381:391–403.
   PubMed Web of Science ®Google Scholar
• Das AK, Som S. Synthesis and evaluation of some 3-benzoylindolizine-1- carboxamides as possible anti-inflammatory and analgesic agents. Orient J Chem. 2006;2:415–420.
   Google Scholar
• Lingala S, Nerella R, Cherukupally R, et al. Synthesis and comparative anti-tubercular activity of indolizine derivatives of Isoniazid/Pyrazinamide/Ethionamide. Int J Pharm Sci Rev Res. 2011;6(2):128–131.
   Google Scholar
• Dinica RM, Furdui B, Ghinea IO, et al. Novel one-pot green synthesis of indolizines biocatalysed by candida antarctica lipases. Mar Drugs. 2013;11:431–439.
   PubMed Web of Science ®Google Scholar
• Singh GS, Mmatli EE. Recent progress in synthesis and bioactivity studies of indolizines. Eur J Med Chem. 2011;46:5237–5257.
   PubMed Web of Science ®Google Scholar
• Olejníková P, Birošová L, Švorc L. Antimicrobial and antimutagenic properties of newly synthesized derivatives of indolizine. Sci Pharm. 2009;77:216.
   Google Scholar
• Wan J, Zheng CJ, Fung MK, et al. Multifunctional electron-transporting indolizine derivatives for highly efficient blue fluorescence, orange phosphorescence host and two-color based white OLEDs. J Mater Chem. 2012;22:4502–4510.
   Web of Science ®Google Scholar
• Song YR, Lim CW, Kim TW. Synthesis and photophysical properties of 1,2-diphenylindolizine derivatives: fluorescent blue-emitting materials for organic light-emitting device. Luminescence. 2015;31:364–371.
   PubMed Web of Science ®Google Scholar
• Delcamp JH, Yella A, Holcombe TW, et al. The molecular engineering of organic sensitizers for solar-cell applications. Angew Chem Int Ed. 2013;52:376–380.
   PubMed Web of Science ®Google Scholar
• Bhat C, Tilve SG. Recent advances in the synthesis of naturally occurring pyrrolidines, pyrrolizidines and indolizidine alkaloids using proline as a unique chiral synthon. RSC Adv. 2014;4:5405–5452.
   Web of Science ®Google Scholar
• Sadowski B, Klajn J, Gryko DT. Recent advances in the synthesis of indolizines and their π-expanded analogues. Org Biomol Chem. 2016;14:7804–7828.
   PubMed Web of Science ®Google Scholar
• Dawood KM. Indolizines, Triazolo[4,3-a]pyridines, Benzimidazo[1,2-d]oxadiazoles and Pyrazolo[1,5-c]triazoles via nitrogen and sulfur ylides. Heteroat Chem. 2004;15:432–436.
   Web of Science ®Google Scholar
• Abdallah TA, Dawood KM. A convenient access to annulated dihydroisoquinoline heterocycles via their nitrogen ylides. Tetrahedron. 2008;64:7890–7895.
   Web of Science ®Google Scholar
• Kheder NA, Darwish ES, Dawood KM. Synthesis of some new indolizine and Pyrrolo[1,2-a]quinoline derivatives via nitrogen ylides. Heterocycles. 2009;78:177–188.
   Web of Science ®Google Scholar
• Dawood KM, Ragab EA, Kheder NA. Facile access to benzothiazole-containing pyrrolo[1,2-a]quinolines and pyrrolo[2,1-a] isoquinolines via nitrogen ylides. J Chin Chem Soc. 2009;56:1180–1185.
   Web of Science ®Google Scholar
• Hea L, Yang Y, Liu X, et al. Iodine-mediated oxidative cyclization of 2-(Pyridin-2-yl)acetate derivatives with alkynes: condition-controlled selective synthesis of multisubstituted indolizines. Synthesis. 2020;52:459–470.
   Web of Science ®Google Scholar
• Burtoloso ACB, Dias RMP, Bernardim B. α,β-unsaturated diazoketones as useful platforms in the synthesis of nitrogen heterocycles. Acc Chem Res. 2015;48:921–934.
   PubMed Web of Science ®Google Scholar
• Pandey G, Dey D, Gadre SR. α-trimethylsilylmethylamine radical cation in the synthesis of cyclic amines and beyond. CHIMIA. 2013;67:30–38.
   PubMed Web of Science ®Google Scholar
• Lapointe G, Kapat A, Weidner K, et al. Radical azidation reactions and their application in the synthesis of alkaloids. Pure Appl Chem. 2012;84:1633–1641.
   Web of Science ®Google Scholar
• Shapland P. Alkaloid synthesis: indolizidines with ease. Nat Chem. 2012;4:441–442.
   PubMed Web of Science ®Google Scholar
• Serdyuk OV, Muzalevskiy VM, Nenajdenko VG. Synthesis and properties of fluoropyrroles and their analogues. Synthesis. 2012;44:2115–2137.
   Web of Science ®Google Scholar
• Kim IS, Jung YH. Recent advances in the total synthesis of indolizidine iminosugars. Heterocycles. 2011;83:2489–2507.
   Web of Science ®Google Scholar
• Bach T, Hehn JP. Photochemical reactions as key steps in natural product synthesis. Angew Chem Internat Ed. 2011;50:1000–1045.
   PubMed Web of Science ®Google Scholar
• Dawood KM. Benzofuran derivatives; a patent review. Expert Opin Therap Pat. 2013;23:1133–1156.
   PubMed Web of Science ®Google Scholar
• Dawood KM, Farghaly TA. Thiadiazole inhibitors: a patent review. Expert Opin Therap Pat. 2017;27:477–505.
   PubMed Web of Science ®Google Scholar
• Behbehani H, Dawood KM, Farghaly TA. Biological evaluation of benzosuberones. Expert Opin Therap Pat. 2018;28:5–29.
   PubMed Web of Science ®Google Scholar
• Dawood KM. An update on benzofuran inhibitors: a patent review. Expert Opin Therap Pat. 2019;29:841–870.
   PubMed Web of Science ®Google Scholar
• Robarge KD, Brunton SA, Castanedo GM, et al. GDC-0449-A potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett. 2009;19:5579–5581.
   Web of Science ®Google Scholar
• Kim ND, Park ES, Kim YH, et al. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Bioorg Med Chem. 2010;18:7092–7100.
   PubMedGoogle Scholar
• Shen YM, Lv PC, Chen W, et al. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line. Eur J Med Chem. 2010;45:3184–3190.
   PubMed Web of Science ®Google Scholar
• Dumea C, Belei D, Ghinet A, et al. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyl transferase. Bioorg Med Chem Lett. 2014;24:5777–5781.
   PubMed Web of Science ®Google Scholar
• Abuhaie CM, Bîcu E, Rigo B, et al. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents. Bioorg Med Chem Lett. 2013;23:147–152.
   PubMed Web of Science ®Google Scholar
• Boot A, Brito A, Wezell TV, et al. Anticancer activity of novel pyrido[2,3-b]indolizineDerivatives: theRelevance of phenolic substituents. Anticancer Res. 2014;34:1673–1678.
   PubMed Web of Science ®Google Scholar
• Lucescu L, Ghinet A, Belei D, et al. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events. Bioorg Med Chem Lett. 2015;25:3957–3979.
   Web of Science ®Google Scholar
• Danac R, Al Matarneh CM, Shova S, et al. New indolizines with phenanthroline skeleton: synthesis, structure antimycobacterial and anticancer evaluation. Bioorg Med Chem. 2015;23:2318–2327.
   PubMed Web of Science ®Google Scholar
• Belal A, Gouda AM, Ahmed AS, et al. Synthesis of novel indolizine, diazepinoindolizine and Pyrimidoindolizine derivatives as potent and selective anticancer agents. Res Chem Intermed. 2015;41:9687–9701.
   Web of Science ®Google Scholar
• Moise IM, Ghinet A, Belei D, et al. New indolizine–chalcones as potent inhibitors of human farnesyltransferase: design, synthesis and biological evaluation. Bioorg Med Chem Lett. 2016;26:3730–3734.
   PubMed Web of Science ®Google Scholar
• Lucescu L, Bîcu E, Belei D. Synthesis and biological evaluation of some new indolizine derivatives as antitumoral agents. Lett Drug Design Discov. 2016;13:1–10.
   Web of Science ®Google Scholar
• Moon SH, Jung Y, Kim SH, et al. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53. Bioorg Med Chem Lett. 2016;26:110–113.
   PubMedGoogle Scholar
• Pal KB, Mahanti M, Huang X, et al. Quinoline-galactose hybrids bind selectively with high affinity to galectin-8 N-terminal domain. Org Biomol Chem. 2018;16:6295–6305.
   PubMed Web of Science ®Google Scholar
• Hay DA, Rogers CM, Fedorov O, et al. Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains. Med Chem Comm. 2015;6:1381–1386.
   Google Scholar
• Ghinet A, Abuhaie CM, Gautret P. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds. Eur J Med Chem. 2015;89:115–127.
   PubMed Web of Science ®Google Scholar
• Sandeep C, Padmashali B, Venugopala KN, et al. Synthesis and characterization of ethyl 7-acetyl-2-substituted 3-(substituted-benzoyl)indolizine-1-carboxylates for in vitro anticancer activity. Asian J Chem. 2016;28:1043–1048.
   Google Scholar
• Krishnan J, Vedhanarayanan B, Sasidhar BS, et al. NHC-mediated synthesis of pyrrolo[2,1-a]isoquinolines and their photophysical investigations. Chem Asian J. 2017;12:623–627.
   PubMed Web of Science ®Google Scholar
• Park S, Kim EH, Kim J, et al. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents. Eur J Med Chem. 2018;144:435–443.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shao E, Zhang Z, et al. A novel indolizine derivative induces apoptosis through the mitochondria p53 pathway in HepG2 cells. Front Pharmacol. 2019;10:762.
   PubMed Web of Science ®Google Scholar
• Tominari Y, Tomata Y, Gamo K, et al. Preparation of piperazine-containing heterocyclic compounds as inhibitors of IAP (inhibitor of apoptosis protein) and proteolysis inducers for prevention or treatment of cancer. WO2020027225A1. 2020
   Google Scholar
• Chen X, Chen Y, Huang Y, et al. Preparation of indolizine compounds for treatment of cancer and autoimmune diseases. PCT Int. Appl. WO 2019170063 A1 20190912. 2019
   Google Scholar
• Cao H, Guo P. Preparation of indolizine compounds with anti-cancer activity. Faming Zh Shenq. CN 108864083 A 20181123. 2018.
   Google Scholar
• Wang W, Deng L, Xiong S, et al. p-Methyl-substituted spiro[indolizine-pyrazoline] derivative containing pyridazinone structure, its preparation method and application as anti-tumor agents. Faming Zh Sheng CN 109232572 A 20190118. 2019.
   Google Scholar
• Zhang A, Ding J, Xie H, et al. Preparation of pyrimido[5,4-b]indolizine or pyrimido[5,4-b]pyrrolizine compounds useful as BTK kinase inhibitors for the treatment of cancer. Faming Zh Shenq CN 108101905 A 20180601. 2018.
   Google Scholar
• Zhang A, Ding J, Xie H, et al. Preparation of pyrimido[5,4-b]indolizine or pyrimido[5,4-b]pyrrolizine compounds useful as BTK kinase inhibitors for the treatment of cancer. PCT Int. Appl WO 2018095398 A1 20180531. 2018.
   Google Scholar
• Chen J, Fu Y, Wang W, et al. Application of indolizine compound containing pyrazole in preparing anticancer drugs. Faming Zh Shenq CN 110251513 A20190920. 2019.
   Google Scholar
• Sagar T, Ito S, Otsuki S, et al. Preparation of 4-amino-6,7,8,9-tetrahydro-5-(3-quinolinyl)pyrimido[5,4-b]indolizine derivatives having EGFR inhibition activities. Taiwan. TW I496783 B 20150821. 2015.
   Google Scholar
• Huang W, Zuo T, Luo X, et al. Indolizine derivatives as HIV-1 VIF–Elongin C interaction inhibitors. Chem Biol Drug Des. 2013;81:730–741.
   PubMed Web of Science ®Google Scholar
• Sinha C, Nischal A, Bandaru S, et al. An in silico approach for identification of novel inhibitors as a potential therapeutics targeting HIV-1 viral infectivity factor. Curr Top Med Chem. 2015;15:65–72.
   PubMed Web of Science ®Google Scholar
• Huang W, Zuo T, Jin H, et al. Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF–Elongin C interaction inhibitors. Mol Divers. 2013;17:221–243.
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu D, Lv W, et al. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and Elongin C. J Virol. 2012;86:5497–5507.
   PubMed Web of Science ®Google Scholar
• Lee WG, Frey KM, Gallardo-Macias R, et al. Discovery and crystallography of bicyclic arylaminoazines as potent inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett. 2015;25:4824–4827.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu X, Huang W, et al. Preparation of indolizine derivatives as antiviral agents. Faming Zh Shenqing CN 103087061 A 20130508. 2013.
   Google Scholar
• Ismail R, Ali MA, Tan SC, et al. Preparation of curcumin compounds containing indolizine for treating HIV, tuberculosis, Alzheimer’s disease and cancer. Malays. Pat MY 160076 A 20170215. 2017.
   Google Scholar
• Ismail R, Ali MA, Tan SC, et al. Preparation of curcumin derivatives containing indolizine. PCT Int. Appl WO 2012099451 A1 20120726. 2012.
   Google Scholar
• Lancois DFA, Guillemont JEG, Raboisson PJ-MB, et al. Preparation of indolizines, pyrazolopyridines, triazolopyridines, pyrazolopyrimidines and imidazopyrimidines having activity against the respiratory syncytial virus (RSV). WO2019206828A1. 2019.
   Google Scholar
• Bosanac T, De LS, Lo HY, et al. Preparation of indolizine inhibitors of leukotriene production. PCT Int. Appl. WO 2010027762 A1 20100311. 2010.
   Google Scholar
• Cao CQ, Wei Y, Zou K, et al. Synthesis and interleukin-6 inhibitory activities of 3-alkyloxylindolizine derivatives. Adv Mat Res. 2013;781:1089–1092.
   Google Scholar
• Wei Y, Cao CQ, Lu XF, et al. Facile synthesis, characterization and anti-inflammatory effect of 3-aminoindolizine derivatives. Adv Mat Res. 2014;881:446–449.
   Google Scholar
• Kumar RS, Antonisamy P, Almansour AI, et al. Discovery of novel cage-like heterocyclic hybrids as anti-inflammatory agents through the inhibition of nitrite, PGE2 and TNF-α. Bioorg Chem. 2019;91:103180.
   PubMed Web of Science ®Google Scholar
• Chandrashekharappa S, Venugopala KN, Tratra C, et al. Efficient synthesis and characterization of novel indolizines: exploration of in vitro COX-2 inhibitory activity and molecular modelling studies. New J Chem. 2018;42:4893–4901.
   Web of Science ®Google Scholar
• Venugopala KN, Al-Attraqchi OHA, Tratrat C, et al. Novel series of methyl 3-(Substituted Benzoyl)-7-substituted-2-phenylindolizine-1-carboxylates as promising anti-inflammatory agents: molecular modeling studies. Biomolecules. 2019;9:661.
   Web of Science ®Google Scholar
• Kumar RS, Antonisamy P, Almansour AI, et al. Functionalized spirooxindole-indolizine hybrids: stereoselective green synthesis and evaluation of anti-inflammatory effect involving TNF-α and nitrite inhibition. Eur J Med Chem. 2018;152:417–423.
   PubMed Web of Science ®Google Scholar
• Sandeep C, Venugopala KN, Khedr MA, et al. Design and synthesis of novel indolizine analogues as COX-2 inhibitors: computational perspective and in vitro screening. Indian J Pharm Edu Res. 2017;51:452–460.
   Web of Science ®Google Scholar
• Shrivastava SK, Srivastava P, Bandresh R, et al. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Bioorg Med Chem Lett. 2017;25:4424–4432.
   Web of Science ®Google Scholar
• Fu Y, Ma J, Shi X, et al. A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway. Biochem Pharmacol. 2017;135:126–138.
   PubMed Web of Science ®Google Scholar
• Jones A, Austin C Preparation of indolizine derivatives and related compounds and their use in the treatment or dermatological and ophthalmic disorders. PCT Int. Appl. WO 2010029364 A1 20100318. 2010.
   Google Scholar
• Attalah KM, Abdalla AN, Aslam A, et al. Ethyl benzoate bearing pyrrolizine/indolizine moieties: design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities. Bioorg Chem. 2020;94:103371.
   PubMed Web of Science ®Google Scholar
• Shawky AM, Abourehab MAS, Abdalla AN, et al. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinonemotif: design, synthesis and investigation of cytotoxicity and anti-inflammatory potency. Eur J Med Chem. 2020;185:111780.
   PubMed Web of Science ®Google Scholar
• Hazra A, Mondal S, Maity A, et al. Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products. Eur J Med Chem. 2011;46:2132–2140.
   PubMed Web of Science ®Google Scholar
• Gomha SM, Dawood KM. Synthesis of novel indolizine, pyrrolo[1,2‑a] quinoline, and 4,5-dihydrothiophene derivatives via nitrogen ylides and their antimicrobial evaluation. J Chem Res. 2014;38:515–519.
   Web of Science ®Google Scholar
• Faghih-Mirzaei E, Seifi M, Abaszadeh M, et al. Design, synthesis, biological evaluation and molecular modeling study of novel indolizine-1-carbonitrile derivatives as potential anti-microbial agents. Iran J Pharm Res. 2018;17(3):883–895.
   PubMed Web of Science ®Google Scholar
• Olejníková P, Birošová L, Švorc L, et al. Newly synthesized indolizine derivatives- antimicrobial and antimutagenic properties. Chem Pap. 2015;69:983–992.
   Web of Science ®Google Scholar
• Muthusaravanan S, Perumal S, Yogeeswari P, et al. Facile three-component domino reactions in the regioselective synthesis and antimycobacterial evaluation of novel indolizines and pyrrolo[2,1-a]isoquinolines. Tetrahedron Lett. 2010;51:6439–6443.
   Web of Science ®Google Scholar
• Danac R, Mangalagiu II. Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III. Eur J Med Chem. 2014;74:664–670.
   PubMed Web of Science ®Google Scholar
• Matviiuk T, Mori G, Lherbet C, et al. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis. Eur J Med Chem. 2014;71:46–52.
   PubMed Web of Science ®Google Scholar
• Olejnikova P, Kurucova M, Švorc L, et al. Induction of resistance in Mycobacterium smegmatis. Can J Microbiol. 2013;59:126–129.
   PubMed Web of Science ®Google Scholar
• Olaru AM, Vasilache V, Danac R, et al. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII. J Enzyme Inhib Med Chem. 2017;32:1291–1298.
   PubMed Web of Science ®Google Scholar
• Kolli MK, Padi KR, Singh N, et al. Synthesis and in vitro antimycobacterial activity of some novel pyrrolo[1,2-a]pyrazine incorporated indolizine derivatives. Pharm Chem. 2018;10(6):153–158.
   Google Scholar
• Khedr MA, Pillay M, Chandrashekharappa S, et al. Molecular Modeling studies and anti-TB activity of trisubstituted indolizine analogues; Molecular docking and dynamic inputs. J Biomol Struct Dynam. 2018;36:2163–2178.
   PubMed Web of Science ®Google Scholar
• Venugopala KN, Chandrashekharappa S, Pillay M, et al. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues. Plos One. 2019;14:e0217270.
   PubMed Web of Science ®Google Scholar
• Venugopala KN, Tratrat C, Pillay M, et al. Anti-tubercular activity of substituted 7-methyl and 7-formylindolizines and in silico study for prospective molecular target identification. Antibiotics. 2019;8:247.
   Web of Science ®Google Scholar
• Hasija A, Bhandary S, Venugopala KN, et al. Structural investigation of methyl 3-(4-fluorobenzoyl)-7-methyl-2-phenylindolizine-1-carboxylate, an inhibitory drug towards Mycobacterium tuberculosis. Acta Crystallogr Sect E: Crystallogr Commun. 2020;76:567–571.
   PubMed Web of Science ®Google Scholar
• Hamdy NA, Gamal-Eldeen AM, Abdel-Aziz HA, et al. Modulation of carcinogen metabolizing enzymes by new fused heterocycles pendant to 5,6,7,8-tetrahydronaphthalene derivatives. Eur J Med Chem. 2010;45:463–470.
   PubMed Web of Science ®Google Scholar
• Zhou H, Danger DP, Dock ST, et al. Synthesis and SAR of benzisothiazole- and indolizine-β-D-glucopyranoside inhibitors of SGLT2. ACS Med Chem Lett. 2010;1:19–23.
   PubMed Web of Science ®Google Scholar
• Mederski W, Beier N, Burgdorf LT, et al. Indolizine derivatives and the use thereof as antidiabetics. US Patent 8, 106,067 B2. 2012.
   Google Scholar
• Chen S, Xia Z, Nagai M, et al. Novel indolizine compounds as potent inhibitors of phosphodiesterase IV (PDE4): structure–activity relationship. Med Chem Comm. 2011;2:176–180.
   Web of Science ®Google Scholar
• Sharma V, Sharma PC, Kumar V. Indolizine derivatives as phosphodiesterase iv inhibitors: development and validation of pharmacophore models. Bull Pharm Res. 2016;6:68–73.
   Google Scholar
• Donnell AF, Dollings PJ, Butera JA, et al. Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors. Bioorg Med Chem Lett. 2010;20:2163–2167.
   PubMed Web of Science ®Google Scholar
• Mahendar B, Mattapally S, Ravinder M, et al. Process for preparation of indolizine derivatives as phosphodiesterase 3 inhibitors. U.S. Pat. Appl. Publ. US 20160159792 A1 20160609. 2016.
   Google Scholar
• Oslund RC, Gelb MH. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A2 and hyaluronic acid-linked inhibitor conjugates. Biochem. 2012;51:8617–8626.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li Y, Qin Z, et al. SAR study on inhibitors of GIIA secreted phospholipase A2 using machine learning methods. Chem Biol Drug Design. 2019;93:666–684.
   PubMed Web of Science ®Google Scholar
• Tavani C, Bianchi L, De Palma A, et al. Nitro-substituted tetrahydroindolizines and homologs: design, kinetics, and mechanism of α-glucosidase inhibition. Bioorg Med Chem Lett. 2017;27:3980–3986.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu H, Song Z. Synthesis and structure–activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors. Bioorg Med Chem Lett. 2017;27:2544–2548.
   PubMed Web of Science ®Google Scholar
• Mainolfi N, Powers J, Meredith E, et al. Core replacements in a potent series of VEGFR-2 inhibitors and their impact on potency, solubility, and hERG. ACS Med Chem Lett. 2016;7:357–362.
   PubMed Web of Science ®Google Scholar
• Liu D, Chen D, Deng B, et al. Preparation of indolizine derivatives useful as HIF prolyl-hydroxylase inhibitors for the treatment of anemia. Faming Zh Shenq CN 108484598 A 20180904. 2018.
   Google Scholar
• Liu D, Chen D, Deng B, et al. Indolizine derivative, preparation and its application in medicine. PCT Int. Appl. WO 2019096089 A1 20190523. 2019.
   Google Scholar
• Liu D, Chen D, Deng B, et al. Indolizine derivative, preparation and its application in medicine. Faming Zh Shenqing CN 107739378 A 20180227. 2018.
   Google Scholar
• Perampalli Nekkar PR, Nambil Kabir S. Preparation of indolizine derivatives as inhibitors of lipoprotein associated phospholipase A2 and 15-lipoxygenase. PCT Int. Appl. WO 2013116948 A1 20130815. 2013.
   Google Scholar
• Roppe JR, Parr T, Stearns BA Indolizine derivatives as 5-lipoxygenase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. PCT Int. Appl. WO 2011038097 A2 20110331. 2011.
   Google Scholar
• Stearns BA, Roppe JR, Parr TA, et al. Preparation of indolizine inhibitors of 5-lipoxygenase for treating respiratory, cardiovascular, and other leukotriene-mediated conditions. PCT Int. Appl. WO 2011038086 A2 20110331. 2011.
   Google Scholar
• Vocadlo DJ, McEachern EJ, Stubbs K Preparation of indolizine derivatives as selective glycosidase inhibitors. PCT Int. Appl. WO 2010012106 A1 20100204. 2010.
   Google Scholar
• Shimizu K, Iizuka M, Takigawa Y Preparation of indolizine derivatives as xanthine oxidase inhibitors. PCT Int. Appl WO 2010113942 A1 20101007. 2010.
   Google Scholar
• Steinhagen H, Scheiper B, Matter H, et al. Preparation of cyclic (aza)indolizine-carboxamides as inhibitors of enzyme renin. PCT Int. Appl. WO 2011012538 A1 20110203. 2011.
   Google Scholar
• Biagetti M, Accetta A, Capelli A, et al. Preparation of indolizine derivatives as phoshoinositide 3-kinases inhibitors. U.S. Pat. Appl. Publ. US 20150361100 A1 20151217. 2015.
   Google Scholar
• Alwassil OI, Chandrashekharappa S, Nayak SK, et al. Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infection. PLoS ONE. 2019;14(10):e0223413.
   PubMed Web of Science ®Google Scholar
• Pike IH, Kuhn K, Kienle S, et al. Preparation of indolizine compound as casein kinase 1inhibitor for the treatment of neurodegenerative disorders. PCT Int. Appl. WO 2016180981 A1 20161117. 2016.
   Google Scholar
• Karra SR, Goutopoulos A. Preparation of indolizine derivatives for the treatment of neurodegenerative diseases. PCT Int. Appl. WO 2016019228 A1 20160204. 2016.
   Google Scholar
• Ihle DC, Guo Q, Hodgetts K, et al. Heteroaryl amide analogues as p2x7 antagonists. US patent US 8,580,812, B2. 2013.
   Google Scholar
• La Pietra V, La Regina G, Coluccia A, et al. Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3b inhibitors. J Med Chem. 2013;56:10066–10078.
   PubMed Web of Science ®Google Scholar
• Alonso JA, Andrés M, Bravo M, et al. Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I. Bioorg Med Chem Lett. 2014;24:5118–5122.
   PubMed Web of Science ®Google Scholar
• Sandeep C, Venugopala KN, Gleiser RM, et al. Greener synthesis of indolizine analogues using water as a base and solvent: study for larvicidal activity against Anopheles arabiensis. Chem Biol Drug Des. 2016;88:899–904.
   PubMed Web of Science ®Google Scholar
• Chandrashekharappa SS, Venugopala KN, Nayak SK. One-pot microwave assisted synthesis and structural elucidation of novel ethyl 3-substituted-7-methylindolizine-1-carboxylates with larvicidal activity against Anopheles arabiensis. J Mol Struct. 2018;1156:377–384.
   Web of Science ®Google Scholar
• Xue Y, Tang J, Ma X, et al. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists. Eur J Med Chem. 2016;115:94–108.
   PubMed Web of Science ®Google Scholar
• Gea Y, Liua A, Donga J, et al. A simple pH fluorescent probe based on new fluorophore indolizine for imaging of living cells. Sens Actuators B. 2017;247:46–52.
   Web of Science ®Google Scholar
• Sung J, Lee Y, Cha JH, et al. Development of fluorescent mitochondria probe based on 1,2-dihydropyrrolo[3,4-b]indolizine-3-one. Dyes Pigm. 2017;145:461–468.
   Web of Science ®Google Scholar
• Kim J, Heo Y, Jung Y, et al. Diversity-oriented functionalization of indolizines at the C3 position via multicomponent Kabachnik-Fields reaction. Tetrahedron. 2017;73:5759–5768.
   Web of Science ®Google Scholar
• Dorange I, Forsblom R, Macsari I, et al. Discovery of novel pyrrolopyridazine scaffolds as transient receptor potential vanilloid (TRPV1) antagonists. Bioorg Med Chem Lett. 2012;22:6888–6895.
   PubMed Web of Science ®Google Scholar
• Li T, Zhao X, Yu C, et al. Preparation of indolizine derivatives as URAT1 inhibitors. PCT Int. Appl. WO 2017114352 A1 20170706. 2017.
   Google Scholar
• Papaioannou N, Fink SJ, Miller TA, et al., Preparation of substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof. PCT Int. Appl WO 2019178129 A1. 2019.
   Google Scholar